Literature DB >> 16469679

Health-related quality of life in patients attending a gastroenterology outpatient clinic: functional disorders versus organic diseases.

Magnus Simrén1, Jan Svedlund, Iris Posserud, Einar S Björnsson, Hasse Abrahamsson.   

Abstract

BACKGROUND & AIMS: Several gastrointestinal (GI) disorders have major effects on health-related quality of life (HRQOL), but there are few direct comparisons between functional GI disorders and organic GI diseases. This study aimed to compare HRQOL between these 2 groups and to assess factors of importance for HRQOL.
METHODS: Three hundred ninety-nine consecutive patients attending a GI outpatient clinic completed HRQOL instruments (Short Form 36 [SF-36] and Psychological General Well-Being index [PGWB]) and the Gastrointestinal Symptom Rating Scale (GSRS). For the analyses we divided the patients into 2 diagnostic groups: functional GI disorders (n = 112) and organic GI diseases (n = 287).
RESULTS: Compared with norm values on SF-36 and PGWB, both patient groups exhibited profound reductions in HRQOL. After correcting for age, gender, and disease duration, patients with a functional GI disorder had significantly lower scores than patients with an organic GI disease on 6 of 8 SF-36 domains and 5 of 6 PGWB domains. Vitality and anxiety on PGWB, abdominal pain and diarrhea on GSRS, age, and gender independently contributed to the physical component score of SF-36 (adjusted R(2) = 32%). Patients with a functional GI disorder had more severe reflux, abdominal pain, constipation, and indigestion, but the severity of diarrhea did not differ between the groups. HRQOL was reduced with increasing severity of GI symptoms.
CONCLUSION: GI disorders have profound effects on HRQOL, and the impact is greater in patients with functional GI disorders as compared with organic GI diseases. The reduction in HRQOL is associated with the severity of both psychological and GI symptoms.

Entities:  

Mesh:

Year:  2006        PMID: 16469679     DOI: 10.1016/s1542-3565(05)00981-x

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  31 in total

1.  What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful?

Authors:  Natasha A Koloski; Philip M Boyce; Michael P Jones; Nicholas J Talley
Journal:  Qual Life Res       Date:  2011-08-11       Impact factor: 4.147

2.  Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?

Authors:  Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 3.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

4.  I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.

Authors:  Vicente Lorenzo-Zúñiga; Elba Llop; Cristina Suárez; Beatriz Alvarez; Luis Abreu; Jordi Espadaler; Jordi Serra
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.

Authors:  Shinta Mizuno; Tatsuhiro Masaoka; Makoto Naganuma; Taishiro Kishimoto; Momoko Kitazawa; Shunya Kurokawa; Moeko Nakashima; Kozue Takeshita; Wataru Suda; Masaru Mimura; Masahira Hattori; Takanori Kanai
Journal:  Digestion       Date:  2017-06-21       Impact factor: 3.216

Review 6.  Intestinal microbiota and its role in irritable bowel syndrome (IBS).

Authors:  Lena Ohman; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2013-05

7.  Five-year follow-up of 263 cases of functional bowel disorder.

Authors:  Yu-Rong Tang; Ping Wang; Rui Yin; Jian-Xin Ge; Guo-Pin Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

8.  Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia.

Authors:  M M Walker; N J Talley; M Prabhakar; C J Pennaneac'h; P Aro; J Ronkainen; T Storskrubb; W S Harmsen; A R Zinsmeister; L Agreus
Journal:  Aliment Pharmacol Ther       Date:  2009-01-17       Impact factor: 8.171

9.  Number of Gastrointestinal Symptoms is a Useful Means of Identifying Patients with Cancer for Dysphagia.

Authors:  Machi Tsukamoto; Noriaki Manabe; Tomoari Kamada; Toshihiro Hirai; Jiro Hata; Ken Haruma; Kazuhiko Inoue
Journal:  Dysphagia       Date:  2016-04-26       Impact factor: 3.438

10.  The Influence of Bifidobacterium bifidum and Bacteroides fragilis on Enteric Glial Cell-Derived Neurotrophic Factors and Inflammasome.

Authors:  Peng-Chun Yang; Xi-Jun Li; Yan-Hua Yang; Wei Qian; Shi-Yu Li; Cai-Hua Yan; Jing Wang; Qin Wang; Xiao-Hua Hou; Chi-Bing Dai
Journal:  Inflammation       Date:  2020-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.